Carbapenem Resistant Enterobacteriaceae in Africa
Open Access
- 21 May 2020
- journal article
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 3 (2), 71-78
- https://doi.org/10.33084/bjop.v3i2.1356
Abstract
Carbapenems are regarded as unique among the β-lactam antibiotics due to their broad spectrum of activity and ability to resist β-lactamase hydrolysis. Carbapenems are the only β-lactam antibiotics with efficacy in severe infections caused by extended-spectrum beta-lactamase (ESBL) producing bacteria. However, recent reports of carbapenem resistance particularly among members of Enterobacteriaceae that are responsible for diseases such as gastrointestinal infections, septicemia, pneumonia, meningitis, peritonitis as well as urinary tract infections, call for concerns. In Africa, the problem of carbapenem-resistant Enterobacteriaceae (CRE) is aggravated by factors such as the high rate of infections, poor diagnostic tools, sub-optimal disease surveillance, and abuse of antibiotics. Besides, the problem of CRE in Africa is understudied. This review distills available literature on the spread of CRE in Africa, CRE genes in circulation, and the need to pay attention to this emerging threat to lives in developing countries.Keywords
This publication has 37 references indexed in Scilit:
- Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in GhanaMicrobial Drug Resistance, 2019
- Carbapenem Resistance: A ReviewMedical Sciences, 2017
- Carbapenem-resistant Enterobacteriaceae in the community: a scoping reviewInternational Journal of Antimicrobial Agents, 2017
- Carbapenem-Resistant EnterobacteriaceaeClinics in Laboratory Medicine, 2017
- Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: Report from the trenchInfection, Genetics and Evolution, 2015
- Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative BacteriaBioMed Research International, 2014
- Antibacterial resistance in sub‐Saharan Africa: an underestimated emergencyAnnals of the New York Academy of Sciences, 2014
- Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013Eurosurveillance, 2013
- Carbapenem antibiotics for serious infectionsBMJ, 2012
- The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.South African Medical Journal, 2012